HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Urologic Oncologists

Urologic Oncologists are surgical and medical experts specializing in the diagnosis, treatment, and management of cancers within the genitourinary system, which includes the kidneys, bladder, prostate, testes, and ureters. These specialists are trained in both urology and oncology, allowing them to employ advanced diagnostic tools, surgical techniques, and targeted therapies for patients with malignancies in these regions. They perform complex surgical procedures such as nephrectomies, cystectomies, prostatectomies, and lymph node dissections, using both traditional and minimally invasive methods to ensure the most effective outcomes while minimizing complications.

Surgical intervention, urologic oncologists are skilled in systemic therapies, including chemotherapy, radiation therapy, and newer modalities such as immunotherapy and targeted molecular treatments. They often work in collaboration with multidisciplinary teams, including medical oncologists, pathologists, radiologists, and radiotherapists, to develop individualized treatment plans that align with the patient's unique pathology and staging. Urologic oncologists also focus on the long-term follow-up care of patients, monitoring for recurrence, managing side effects, and enhancing survivorship through rehabilitation and support services. Their dual expertise in both surgery and oncologic care ensures that patients receive a comprehensive, patient-centered approach, addressing both the disease and the broader aspects of health and well-being. By staying at the forefront of medical advancements, urologic oncologists continue to improve survival outcomes and offer hope to patients facing complex conditions.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp